People · Operator
Named in public records as an officer, director or promoter · active 2009–2010 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sagent Holding Co. | — | Pharmaceuticals | Series B | $45.8M | $204.0M | 2009 |
James Sperans at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Sperans on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Chen Yu | 1 | 7 |
| Robert Flanagan | 1 | 4 |
| Jeffrey Yordon | 1 | 3 |
| Frank Kung | 1 | 2 |
| Ronald E. Pauli | 1 | 1 |
| Anthony Krizman | 1 | 1 |
| Ronald Pauli | 1 | 1 |
| Mark Qiu | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.